Asia-Pacific transcatheter aortic valve replacement (TAVR) market is expected to reach USD 1.08 billion by 2022 from USD 0.41 billion in 2017, growing at a CAGR of 21.20% during the forecast period 2016-2022. Transcatheter aortic valve replacement (TAVR) is described as minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery for the benefit of high risk patients. Transcatheter heart valve replacement systems are referred as cardiovascular devices replace the old and damaged valves. TAVR is used for the treatment of aortic valve disorders such as severe aortic stenosis, degeneration, & regurgitation. Transcatheter aortic valve replacement devices are integrated with valve frame (made of nitinol or stainless steel), valve leaflets material (made of bovine or cow heart tissue). These aortic valves are available with varied sizes (such as 14mm, 16mm, 18mm, 20mm, 22mm, & 29mm). TAVR is performed during different surgery methods such as transfemoral implantation (through the femoral artery), transapical implantation (through the apex of the heart), transaortic implantation (through the top of right chest), and transcaval implantation (through the femoral vein).



Increasing aging population (large elder population in Japan) & patient population, rising number of product launches in this market, and growing number of cardiovascular diseases (valvular heart diseases) are driving the growth of transcatheter aortic valve replacement (TAVR) market in Asia-Pacific region. However, unaffordability of TAVR procedures and limited adoption of transcatheter aortic valve systems are restraining the growth of transcatheter aortic valve replacement (TAVR) market in Asia-Pacific region.

View full report @ http://www.marketdataforecast.com/market-reports/asia-pacific-transcatheter-aortic-valve-replacement-market-360/



Asia-Pacific transcatheter aortic valve replacement (TAVR) market is segmented based on surgery method, valve frame material, valve size, valve leaflets material, and end users. Based on surgery method, the market is sub-segmented as transfemoral implantation, transapical implantation, transaortic implantation, and transcaval implantation. Of these, transfemoral is estimated to command the largest share of Asia-Pacific transcatheter aortic valve replacement (TAVR) market by surgery method in 2016 and expected to grow at the highest CAGR during the forecast period. Based on valve frame material, the market is segmented as nitinol, stainless steel, and cobalt-chromium. Of these, nitinol segment is expected to account for the largest share of Asia-Pacific transcatheter aortic valve replacement (TAVR) market by valve frame material in 2016.



Transcatheter valve size market is segmented as 14mm to 18mm, 18mm to 22mm, and 22mm to 29mm. Based on valve leaflets material, the market is segmented as bovine heart tissue, cow heart tissue, and other valve leaflets material. Based on end users, the market is sub-segmented as hospitals, ambulatory surgical centres, & cardiac catheterization laboratories. Of these, hospital segment held the largest share of Asia-Pacific transcatheter aortic valve replacement (TAVR) market by end users in 2016.

Market Segmentation:

1 Diagnostic Type

2 Surgery Type
Get free sample report @ http://www.marketdataforecast.com/market-reports/asia-pacific-transcatheter-aortic-valve-replacement-market-360/request-sample

On the basis of geographical areas, Asia-Pacific transcatheter aortic valve replacement (TAVR) market is segmented as Japan, China, India, Australia, and South Korea.

Scope of the report:

Global, regional and country-level analysisand forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysisin terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC)in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysisfor analysing the level of competition and business strategy development



The key players in transcatheter aortic valve replacement (TAVR) market such as, Edwards Lifesciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India), and Braile Biomedica (Brazil).

About Market Data Forecast:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com



Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: [email protected]

Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases